Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.140 +0.050 (+0.55%)
Streaming Delayed Price Updated: 3:43 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Top movers in Friday's after hours session ↗
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
A Look Ahead: Prothena Corp's Earnings Forecast ↗
 
Via Benzinga
News headline image
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 20, 2025 ↗
 
Via Benzinga
News headline image
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
 
Via Benzinga
Topics Stocks
News headline image
Demystifying Prothena Corp: Insights From 6 Analyst Reviews ↗
 
Via Benzinga
News headline image
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease ↗
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients. 
Via Investor's Business Daily
News headline image
Expert Ratings For Prothena Corp ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Earnings Preview For Prothena Corp ↗
 
Via Benzinga
News headline image
Breaking Down Prothena Corp: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits ↗
Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses. 
Via Benzinga
News headline image
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Dow Dips 300 Points; Emcore Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Demystifying Prothena Corp: Insights From 8 Analyst Reviews ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher ↗
 
Via Benzinga
News headline image
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024 ↗
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win ↗
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday. 
Via Investor's Business Daily
News headline image
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 ↗
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback ↗
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.